Roche bolstered the Swiss pharma giant’s diagnostics capabilities by acquiring the company’s long-term partner, TIB Molbiol. The procurement will expand Roche’s PCR-test portfolio capabilities in the ongoing fight against existing and emerging infectious diseases, including new Covid-19 variants of interest.
Genetic testing specialist Qiagen received emergency use authorization for a new coronavirus test from the U.S. drugs regulator.
French researchers are using tiny antibody particles extracted from the family of animals that includes camels and llamas to produce a test they say can detect if patients have Covid-19 faster and more accurately than existing methods.
Silicon Valley medical equipment startup Visby Medical received Emergency Use Authorization by the U.S. Food and Drug Administration for a portable PCR Covid-19 test kit, the first company to do so, according to the FDA.
Clinical diagnostics company Novacyt, one of many healthcare companies whose shares have surged during the pandemic, launched a test to differentiate between Covid-19 and common winter diseases.
A hospital in the southern French city of Lyon is testing patients with a new machine that enables them to breathe into a tube to see whether they have Covid-19 in a matter of seconds.
Weeks after Mammoth Biosciences announced the company’s CRISPR-based diagnostics test for COVID-19 had a high degree of specificity even for asymptomatic patients, the Bay Area-based firm struck a deal with GlaxoSmithKline to accelerate development of the test in hopes of getting them in consumer hands as soon as possible.
While most of us are concerned about Lyme disease, a tickborne illness circulating during the spring and summertime in the Northeastern U.S, there is another, potentially more serious infection to be aware of as well. The causative organism behind Lyme disease, the spirochete Borriela burgdorferi, is not alone. An emerging tickborne infection in the Northeastern […]